Incidental detection of a papillary thyroid cancer by 18F-FDG PET-CT study in a patient with metastatic colorectal cancer

2010 ◽  
Vol 29 (6) ◽  
pp. 312-313
Author(s):  
J. Banzo ◽  
M.A. Ubieto ◽  
J. Villalta ◽  
P. Razola ◽  
E. Prats ◽  
...  
2012 ◽  
Vol 37 (9) ◽  
pp. e234-e236 ◽  
Author(s):  
Camila Mosci ◽  
I. Ross McDougall ◽  
R. Brooke Jeffrey ◽  
Andrei Iagaru

2020 ◽  
Vol 13 (1) ◽  
pp. 37-42
Author(s):  
Hyungi Gim ◽  
Dong Kun Lee ◽  
Heon Soo Park ◽  
Yeong Jin Jeong

2010 ◽  
Vol 35 (5) ◽  
pp. 357-359 ◽  
Author(s):  
Josephine N. Rini ◽  
Vinh T. Nguyen ◽  
Eran Ben-Levi ◽  
Jason J. Naidich ◽  
Jian Yi Li ◽  
...  

2017 ◽  
Vol 28 ◽  
pp. iii12
Author(s):  
Angelica Nazarian ◽  
Zoe Andrada ◽  
Joanne Thomas ◽  
Sudipta Sureshbabu ◽  
Nathaniel Berman ◽  
...  

2020 ◽  
Vol 49 (1) ◽  
pp. 1
Author(s):  
Emir Sokolović ◽  
Timur Cerić ◽  
Šejla Cerić ◽  
Semir Bešlija ◽  
Sandra Vegar-Zubović ◽  
...  

<p><strong>Objective. </strong>The aim of the study was to evaluate the prognostic value of the maximum standardized uptake value (SUVmax) of 18F-Fluorodeoxyglucose (18F-FDG) PET/CT in patients with metastatic colorectal cancer, and to compare it with classical prognostic markers.</p><p><strong>Materials and Methods. </strong>The study included 70 patients with metastatic colorectal cancer who had not been treated for the metastatic disease. The patients underwent 18F-FDG PET/CT as part of their routine diagnostic reevaluation. During the analysis, the value of the largest tumor diameter and SUVmax was determined for the lesion with the highest SUVmax observed. The values of CEA and CA 19-9 were recorded 7 days before the PET/CT analysis.</p><p><strong>Results. </strong>SUVmax and Carbohydrate antigen (CA)19-9 were found to be independent prognostic markers of disease progression within 12 months. Based on the Receiver Operating Characteristics (ROC) curve analysis, the patients could be divided into two groups: SUVmax≤4.1 vs. SUVmax&gt;4.1. Patients with SUVmax values of 4.1 or less had significantly better progression-free survival within 12 months with an HR (95% CI) of 2.97 (1.4-6.3), relative to patients with SUVmax values above 4.1.</p><p><strong>Conclusion. </strong>SUVmax may be used as a novel prognostic marker of disease progression among patients with metastatic colorectal cancer. Values of SUVmax can be used to select patients with a more aggressive type of disease and higher risk for progression within 12 months of PET/CT analysis.</p>


2012 ◽  
Vol 1 (2) ◽  
pp. 78-86 ◽  
Author(s):  
Mubashir Mulla ◽  
Klaus-Martin Schulte

Cervical lymph nodes (CLNs) are the most common site of metastases in papillary thyroid cancer (PTC). Ultrasound scan (US) is the most commonly used imaging modality in the evaluation of CLNs in PTC. Computerised tomography (CT) and 18fluorodeoxyglucose positron emission tomography (18FDG PET–CT) are used less commonly. It is widely believed that the above imaging techniques should guide the surgical approach to the patient with PTC.MethodsWe performed a systematic review of imaging studies from the literature assessing the usefulness for the detection of metastatic CLNs in PTC. We evaluated the author's interpretation of their numeric findings specifically with regard to ‘sensitivity’ and ‘negative predictive value’ (NPV) by comparing their use against standard definitions of these terms in probabilistic statistics.ResultsA total of 16 studies used probabilistic terms to describe the value of US for the detection of LN metastases. Only 6 (37.5%) calculated sensitivity and NPV correctly. For CT, out of the eight studies, only 1 (12.5%) used correct terms to describe analytical results. One study looked at magnetic resonance imaging, while three assessed 18FDG PET–CT, none of which provided correct calculations for sensitivity and NPV.ConclusionImaging provides high specificity for the detection of cervical metastases of PTC. However, sensitivity and NPV are low. The majority of studies reporting on a high sensitivity have not used key terms according to standard definitions of probabilistic statistics. Against common opinion, there is no current evidence that failure to find LN metastases on ultrasound or cross-sectional imaging can be used to guide surgical decision making.


2016 ◽  
Vol 55 (9-10) ◽  
pp. 1175-1182 ◽  
Author(s):  
Kristin Skougaard ◽  
Dorte Nielsen ◽  
Benny Vittrup Jensen ◽  
Per Pfeiffer ◽  
Helle Westergren Hendel

Sign in / Sign up

Export Citation Format

Share Document